-

Decaffeinated Coffee Market Report 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Decaffeinated Coffee Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global decaffeinated coffee market to grow with a CAGR of 7% over the forecast period from 2022-2028.

The report on the global decaffeinated coffee market provides qualitative and quantitative analysis for the period from 2022 to 2028. The study on the decaffeinated coffee market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.

The report on decaffeinated coffee market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global decaffeinated coffee market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global decaffeinated coffee market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

Drivers

  • Growing number of people are switching to a healthy lifestyle
  • Growing consumer base

Restraints

  • Harmful effects of coffee

Opportunities

  • Growing disposable income of people

Company Profiles

  • Kraft Heinz Company
  • Colombian Brew Ground Coffee
  • Don Pablo Coffee
  • Cravium Foods LLP
  • Dunkin' Brands Group, Inc.
  • Nestle S.A.
  • Lifeboost Coffee
  • Kicking Horse Coffee Co. Ltd.
  • Koffee Kult
  • Cafedirect PLC

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Decaffeinated Coffee Market Highlights

2.2. Decaffeinated Coffee Market Projection

2.3. Decaffeinated Coffee Market Regional Highlights

3. Global Decaffeinated Coffee Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Analysis of COVID-19 impact on the Decaffeinated Coffee Market

3.4. Porter's Five Forces Analysis

3.5. Growth Matrix Analysis

3.5.1. Growth Matrix Analysis by Product

3.5.2. Growth Matrix Analysis by Bean Type

3.5.3. Growth Matrix Analysis by Distribution Channel

3.5.4. Growth Matrix Analysis by Region

3.6. Value Chain Analysis of Decaffeinated Coffee Market

4. Decaffeinated Coffee Market Macro Indicator Analysis

5. Global Decaffeinated Coffee Market by Product

5.1. Roasted

5.2. Raw

6. Global Decaffeinated Coffee Market by Bean Type

6.1. Arabica

6.2. Robusta

6.3. Others

7. Global Decaffeinated Coffee Market by Distribution Channel

7.1. Online

7.2. Offline

8. Global Decaffeinated Coffee Market by Region 2022-2028

8.1. North America

8.1.1. North America Decaffeinated Coffee Market by Product

8.1.2. North America Decaffeinated Coffee Market by Bean Type

8.1.3. North America Decaffeinated Coffee Market by Distribution Channel

8.1.4. North America Decaffeinated Coffee Market by Country

8.2. Europe

8.3. Asia-Pacific

8.4. RoW

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Decaffeinated Coffee Market

9.2. Companies Profiled

For more information about this report visit https://www.researchandmarkets.com/r/7xeizv

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Platinum-Based Catalysts Market Outlook to 2029 & 2034: Revenues to Reach $4.98 Billion by 2029 - Industry Leaders are Sinopec Catalyst Co., BASF, Thermo Fisher Scientific, and Linde - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Platinum-Based Catalysts Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The platinum-based catalysts market has experienced robust growth recently, with its value expected to expand from $3.67 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. This previous growth is primarily driven by the automotive industry's demand, stricter environmental regulations, fuel cell technology adoption, and the...

Middle East Colocation Data Center Portfolio Analysis Report 2025: Khazna Data Centers, Saudi Telecom Company and Gulf Data Hub Rank Among the Leading Data Center Operators by Capacity - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Middle East Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Middle East hosts around 170+ existing data centers, with countries like the UAE & Saudi Arabia having a strong presence in the region. Khazna Data Centers, Saudi Telecom Company and Gulf Data Hub rank among the leading data center operators by capacity across Middle East. The United Arab Emirates dominates the existing market with a power ca...

CD22 Targeted Therapies Market Research Report 2025-2026: Approved Drug Sales, Technology Platforms & Clinical Trials Insights - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CD22 Targeted Therapies Market, Approved Drug Sales, Technology Platforms & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Current & Future Global Market Outlook Insight on CD22 Targeted Approaches Approved Drug Dosage, Price & Sales Insight CD22 Targeted Therapies Development Trends by Region & Indications CD22 Targeted Therapies in Clinical Trials: > 20 Therapies CD22...
Back to Newsroom